Middle East and North Africa Conference (MENA)

This two-day conference is designed for the industry's regulatory professionals to explore the evolving pharmaceutical landscape in the MENA region and address its unique challenges, with all regional regulators present.

返回 Agenda

Parallel Session 5B: Rare Diseases

Session Chair(s)

Yazeed AlRuthia

Professor, Department of Clinical Pharmacy

King Saud University, College of Pharmacy, Saudi Arabia

Niveen Osman, MBA

Regulatory Affairs Director

Amgen Inc., United Arab Emirates

Topics addressed in this session include: Orphan Drugs’ regulations in the region, national plans for rare diseases, best practices from Europe and other regions.

Speaker(s)

Panel Discussion with Q&A

Marco Rafael, PharmD, MBA, RPh

Roche, Switzerland

Regulatory Policy Lead

Panel Discussion with Q&A

Kristina Larsson, MS

European Medicines Agency, Netherlands

Head of Orphan Medicines, Division for Human Medicines Evidence Generation

Middle East and North Africa Conference (MENA)

Parallel Session 5B: Rare Diseases

Session Chair(s)

Yazeed AlRuthia

Niveen Osman, MBA

Speaker(s)

Panel Discussion with Q&A

Panel Discussion with Q&A

获得信息并保持参与